In essence, Retatrutide tackles three metabolic pathways at once, resulting in greater efficacy in lowering blood glucose and body fat than single- or dual-agonist therapies
pain reduction radical scavenger and antioxidant actions gastric mucosa healing stomach cell protection against noxious agents improving the healing of intestinal tissues increased vessel recruitment following injury induction improving short-bowel syndrome Unofficially, the peptide has also been claimed to help burn fat, increase muscle, heal the heart, lower blood pressure, help with erectile dysfunction, and increase HGH levels, but there is no data to suggest that, even from lab studies
Safety and administration The evidence in human trials shows AOD 9604 as safe for human consumption
CagriSema produced unprecedented mean weight loss of 20.4% at 68 weeks on an intent-to-treat basis, significantly exceeding semaglutide alone (14.9%), cagrilintide alone (11.5%), and placebo (3.0%)
Produced by Nexwin Pharma, it is widely recommended for B12 deficiency, neuropathy, and general nerve support